RGNX
Regenxbio Inc
Price:  
9.30 
USD
Volume:  
934,781.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGNX WACC - Weighted Average Cost of Capital

The WACC of Regenxbio Inc (RGNX) is 7.2%.

The Cost of Equity of Regenxbio Inc (RGNX) is 9.40%.
The Cost of Debt of Regenxbio Inc (RGNX) is 5.00%.

Range Selected
Cost of equity 7.90% - 10.90% 9.40%
Tax rate 1.70% - 3.70% 2.70%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.4% - 7.9% 7.2%
WACC

RGNX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.89 1.08
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 10.90%
Tax rate 1.70% 3.70%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.4% 7.9%
Selected WACC 7.2%